GGrantIndex
← Leaderboards

Nhan L Tran

Translational Genomics Research Inst

Google Scholar ↗PubMed ↗ORCID ↗
$7,237,767
Attributed
$11,588,452
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,588,452 · 9

By mechanism

R01$5,835,680 · 4
U01$4,302,486 · 1
R56$580,194 · 1
R41$399,998 · 1
U54$356,003 · 1
F32$114,091 · 1

Top collaborators

Most similar at Translational Genomics Research Inst

Same institution · by research overlap

Others in their field

Top investigators on “Brain”

Research focus

BrainTumorCellsGlioblastomaMolecularExcisionOperative Surgical ProceduresMutationRecurrenceTherapeutic TargetTherapy ResistantTumor GrowthSignal TransductionGliomaPatternPhenotypeSignal PathwayCell LineMediatingResistanceIn VitroPharmaceutical PreparationsHeterogeneityFuture

Grant awards (31)

STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22$595,640
R01 · FY2025 · CA · contact PI
STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22$565,756
R01 · FY2024 · CA · contact PI
MOSAIC: Targeting the Tissue State$12,590
U54 · FY2024 · CA · contact PI
STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22$629,642
R01 · FY2023 · CA · contact PI
MOSAIC: Targeting the Tissue State$343,413
U54 · FY2023 · CA · contact PI
Chemosensitization of Glioblastoma by Propentofylline$399,998
R41 · FY2022 · CA · contact PI
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$667,615
U01 · FY2021 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$166,000
U01 · FY2021 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$73,936
U01 · FY2021 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$952,700
U01 · FY2020 · CA
Enhancing Treatment Response by Leveraging STAT5-OLIG2 signaling in GBM$580,194
R56 · FY2020 · NS · contact PI
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$71,260
U01 · FY2020 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$651,460
U01 · FY2019 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$73,936
U01 · FY2019 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$929,069
U01 · FY2018 · CA
TROY HTS Compound Screening$432,568
R01 · FY2018 · NS · contact PI
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma$716,510
U01 · FY2017 · CA
TROY HTS Compound Screening$430,566
R01 · FY2017 · NS · contact PI
TROY HTS Compound Screening$432,510
R01 · FY2016 · NS · contact PI
TROY HTS Compound Screening$22,906
R01 · FY2016 · NS · contact PI
TWEAK-Fn14 HTS compound screening$390,619
R01 · FY2015 · CA · contact PI
TWEAK-Fn14 HTS compound screening$383,429
R01 · FY2014 · CA · contact PI
TWEAK-Fn14 HTS compound screening$421,457
R01 · FY2013 · CA · contact PI
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas$336,935
R01 · FY2012 · CA · contact PI
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas$291,648
R01 · FY2011 · CA · contact PI
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas$300,668
R01 · FY2010 · CA · contact PI
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas$300,668
R01 · FY2009 · CA · contact PI
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas$300,668
R01 · FY2008 · CA · contact PI
Translational Studies of Fn14 in Brain Tumors$12,115
F32 · FY2007 · CA · contact PI
Translational Studies of Fn14 in Brain Tumors$52,048
F32 · FY2006 · CA · contact PI
Translational Studies of Fn14 in Brain Tumors$49,928
F32 · FY2005 · CA